Impaired Non-Esterified Fatty Acid Suppression is Associated with Endothelial Dysfunction in Insulin Resistant Subjects

In a recent study, we found a significant association between insulin resistance (IR) and disturbed flow-associated (endothelial-dependent) vasodilation in first-degree relatives of subjects with type 2 diabetes. However, the mechanisms linking insulin resistance and endothelial dysfunction (ED) have not been fully elucidated. Experimental data have pointed out that non-esterified fatty acids (NEFA) have a modulating effect on NO-synthase activity, and therefore on endothelial function. The aim of our study was to evaluate whether insulin resistance associated impaired NEFA suppression is present in subjects with ED. We examined 53 first-degree relatives (FDR) of patients with type 2 diabetes (32f, 21m, mean age 35 years). Endothelial function was measured as flow-associated vasodilation (FAD%) of the brachial artery. Insulin sensitivity was evaluated with a standard hyperinsulinemic glucose clamp (insulin infusion rate of 1 mU/kg/min). While under fasting conditions, NEFA did not differ between groups with high or low FAD (0.415 ± 0.033 vs. 0.394 ± 0.040 mmol/l; p = n. s.), reduced FAD% was significantly associated with higher non-esterified fatty acids concentrations during steady state of the glucose clamp (0.072 ± 0.022 vs. 0.039 ± 0.016 mmol/l; p = 0.04). This association was independent of insulin levels under fasting conditions and during the glucose clamp. In conclusion, our results reveal a significant association between endothelial dysfunction and impaired non-esterified fatty acid suppression in insulin resistant subjects. As insulin resistance of lipolysis is a feature of the insulin resistance syndrome, these results suggest that elevated NEFA concentrations could play a role linking endothelial dysfunction and insulin resistance in vivo.

Key words:

Endothelial Dysfunction - Insulin Resistance - Cardiovascular Risk Factors - Atherosclerosis

References

• 1 Balletshofer B M, Rittig K, Enderle M, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Häring H U. Endothelial dysfunction is detectable in young normotensive first degree relatives of subjects with type 2 diabetes in association with insulin resistance.  Circulation. 2000;  101 1780-1784
• 2 Joannides R, Haefeli W, Linder L, Richard V, Bakkali E H, Thuillez C, Lüscher T F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. .  Circulation. 1995;  91 1314-1319
• 3 Davda R K, Stepniakowski K T, Lu G, Ullian M E, Goodfriend T L, Egan B M. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism.  Hypertension. 1995;  26 764-770
• 4 Ferrannini E, Camastra S, Coppack W, Fliser D, Golay A, Mitraku A, on behalf of the European Group for the Study of Insulin Resistance (EGIR). Insulin action and non-esterified fatty acids.  Proc Nut Soc. 1997;  56 753-761
• 5 Golay A, Chen Y D, Reaven G M. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism.  J Clin Endocrin Metab. 1986;  62 1081-1088
• 6 Golay A, Swisloki A L, Chen Y D, Jaspan J B, Reaven G M. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.  J Clin Endocrinol Metab. 1986;  63 481-484
• 7 De Fronzo R A, Tobin J D, Andres R. Glucose clamp technique. A method for quantifying insulin secretion and resistance.  Am J Physiol. 1979;  273 E214-E223
• 8 Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR).  Diabetes. 1996;  45 947-953
• 9 Volk A, Renn W, Overkamp D, Mehnert B, Maerker E, Jacob S, Balletshofer B, Haring H U, Rett K. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.  Exp Clin Endocrinol Diabetes. 1999;  107 (2) 140-147
• 10 Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system.  Clin Physiol. 1991;  11 565-577
• 11 Morris M J. SPSS/PC⁺: SPSS for the IBM PC/XT/AT SPSS inc.  Chicago:; 1986
• 12 Swislocki A LM, Chen Y -DI, Golay A, Chang M -O, Reaven G M. Insulin suppression of plasma NEFA concentrations in normal individuals and patients with Type 2 (non-insulin-dependent) diabetes.  Diabetologia. 1987;  30 622-626
• 13 Kooner J S, Baliga R R, Wilding J, Crook D, Packard C J, Banks L, Peart S, Aitman T J, Scott J. Abdominal obesity, impaired non-esterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction.  Arterioscler Thromb Vasc Biol. 1998;  18 1021-1026
• 14 Steinberg H O, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron A. Elevated Circulating NEFA Levels Impair Endothelium-Dependent Vasodilation.  JCI. 1997;  100 1230-1239